drugset
drugset / Trial / NCT03998293

Direct Measurement of Proinsulin Clearance in Humans

NCT03998293 ↗

Phase 4 Withdrawn Mayo Clinic National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
NaSingle-groupOpen-labelBasic science

Summary

Researchers are trying to determine how quickly proinsulin is cleared from the circulation.

Timeline

Start
2022-11
Primary completion
2023-12
Completion
2023-12

Outcome

Outcome not reported

Stopped: “Newly available data suggests that measuring proinsulin clearance would not enhance predictive value of serum proinsulin”

Drugs

EvaluationDrugModalityDoseRoute
Background Somatostatin Traditional medicine (herbal / TCM) — Other

Indications

No indication recorded.